BioStem Awarded a Spot on ECAT, DAPA, and FSS Contract Vehicles Through SDVOSB, Lovell
06 sept. 2023 12h00 HE
|
BioStem Technologies, Inc.
PENSACOLA, FL, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Lovell® Government Services (‘Lovell’) and BioStem Technologies (POMPANO BEACH, FL, ‘BioStem’) announced today that they have successfully listed...
BioStem Technologies Commends OIG's Recommendation for CMS to Address ASP Reporting Requirements for Skin Substitute Products
23 mars 2023 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., March 23, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies (“BioStem” or the “Company”) (OTCQB: BSEM), a leading provider of innovative regenerative medicine solutions, is...
BioStem Technologies to Acquire Majority of Assets of Auxocell Laboratories, Inc.
07 mars 2023 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., March 07, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company”) (OTCQB: BSEM), announced today that it has entered into an Agreement to acquire the...
BioStem Technologies Enters Into a Share Exchange Agreement
14 févr. 2023 08h55 HE
|
BioStem Technologies, Inc.
The Company will Acquire Back 10% of Issued and Outstanding Shares of its Non-Wholly Owned Subsidiary and Manufacturing Division POMPANO BEACH, FLORIDA., Feb. 14, 2023 (GLOBE NEWSWIRE) -- BioStem...
BioStem Technologies Poised for Growth with Two New Hires: Michael Sylvester Joins as Vice President of Sales, Neal Bhattacharya as Vice President of Marketing
01 févr. 2023 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Feb. 01, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company) (OTCQB: BSEM), a leading regenerative medicine company focused on the development,...
Center for Medicare Services Established National Pricing of VENDAJETM in All MAC regions
24 janv. 2023 07h30 HE
|
BioStem Technologies, Inc.
Pricing Provides VENDAJETM Reimbursement in All MAC Regions POMPANO BEACH, FLORIDA., Jan. 24, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTCQB: BSEM), a leading regenerative medicine...
BioStem Technologies Announces Up-Listing to the OTCQB Venture Market
16 déc. 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Dec. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTCQB: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...